Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Health Care Financ Rev ; 24(4): 89-100, 2003.
Article in English | MEDLINE | ID: mdl-14628402

ABSTRACT

Medicare's health care quality improvement program (HCQIP) is a national effort to improve beneficiaries' quality of care. The end stage renal disease (ESRD) HCQIP was implemented in 1994 in response to criticism about the poor quality of care received by ESRD patients. Quality improvement efforts initiated by the ESRD Networks and dialysis providers in response to the HCQIP have demonstrated substantial improvement in care for dialysis patients. This article describes the evolution of the ESRD HCQIP and its successful application in the ESRD program.


Subject(s)
Kidney Failure, Chronic/therapy , Medicare/standards , Quality Assurance, Health Care/organization & administration , Renal Dialysis/standards , Adult , Aged , Centers for Medicare and Medicaid Services, U.S. , Hematocrit , Humans , Kidney Failure, Chronic/economics , Middle Aged , Program Development , Program Evaluation , Quality Indicators, Health Care , Renal Dialysis/adverse effects , Serum Albumin/analysis , United States , Urea/analysis
2.
Am J Kidney Dis ; 42(4): 806-12, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14520632

ABSTRACT

BACKGROUND: The National Kidney Foundation-Dialysis Outcomes Quality Initiative (NKF-DOQI) Clinical Practice Guidelines established a widely accepted set of recommendations for high-quality dialysis care. To enhance the End-Stage Renal Disease Core Indicators Project, an ongoing effort to assess and improve dialysis care in the United States, the Centers for Medicare and Medicaid Services (CMS) commissioned a project to develop clinical performance measures (CPMs) based on the NKF-DOQI guidelines. METHODS: The CMS contracted with Qualis Health, a private nonprofit organization serving as a Medicare Quality Improvement Organization, to facilitate a 9-month project to develop dialysis CPMs with the participation of a broad range of stakeholders from the renal community. Work groups were established to develop CPMs addressing 4 areas: hemodialysis adequacy, peritoneal dialysis adequacy, vascular access management, and anemia management. The NKF-DOQI guidelines were prioritized based on the strength of the evidence supporting the guidelines, the feasibility of developing performance measures, and the significance of the areas addressed to the quality of care delivered to dialysis patients. Expert panels developed data specifications, sampling approaches, data-collection tools, and analytic strategies. RESULTS: Sixteen CPMs were developed based on 22 of 114 NKF-DOQI guidelines. After establishing reliability through field-testing of data-collection instruments, the CPMs were applied to a sample of 8,838 randomly selected hemodialysis patients and 1,650 randomly selected adult peritoneal dialysis patients in summer 1999. CONCLUSION: The development of CPMs based on the NKF-DOQI Clinical Practice Guidelines for dialysis care was accomplished in a timely and effective manner by engaging a broad range of stakeholders and technical experts. The CPMs are important tools to assess and improve the quality of dialysis care in the United States. Few comparable efforts exist in other fields of medicine.


Subject(s)
Clinical Competence/standards , Kidney Failure, Chronic/therapy , Peritoneal Dialysis/standards , Practice Guidelines as Topic , Renal Dialysis/standards , Allied Health Occupations/standards , Consensus , Humans , Nephrology/standards , Treatment Outcome , United States
3.
Kidney Int ; 64(2): 623-31, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12846759

ABSTRACT

BACKGROUND: There is a paucity of information regarding the clinical experience of Asian hemodialysis patients. This paper describes intermediate outcomes for adult Asian hemodialysis patients compared to Caucasians and African Americans. METHODS: Dialysis facility staff abstracted clinical information on a national random sample of adult hemodialysis patients from October through December 2000. Associations of race with intermediate outcomes were tested by bivariate analyses and multivariable logistic regression modeling. RESULTS: A total of 429 patients were identified as Asian, 4403 as Caucasians, and 3103 as African Americans. Asian and Caucasian patients were older than African Americans [mean 63.2 (+/-15.6), 63.9 (+/-15.2), and 57.7 (+/-14.7) years, P < 0.001], and had fewer years on dialysis [mean 3.5 (+/-3.8), 3.1 (+/-3.8), and 4.1 (+/-4.1) years, P < 0.001]. Ninety three percent of Asians, 87% of Caucasians, and 84% of African Americans had a mean Kt/V > or =1.2 (P < 0.001). In addition, 36% of Asians, 32% of Caucasians, and 26% of African Americans had an arteriovenous (AV) fistula as their vascular access (P < 0.001). Hemoglobin profiles were only slightly different among the three racial groups. More Asians and African Americans had a mean serum albumin > or =4.0/3.7 g/dL compared to Caucasians (33% and 31% compared to 27%, respectively, P < 0.001). In the final multivariable logistic regression model, Asians were twice as likely to have a mean Kt/V > or =1.2 compared to Caucasians (the referent group) [odds ratio (OR) (95% CI) 2.10 (1.33, 3.32), P < 0.01]. They experienced similar intermediate outcomes for vascular access, anemia management, and serum albumin compared to the majority racial group. CONCLUSION: These findings indicate that adult hemodialysis Asian patients experience similar or better intermediate outcomes compared to the majority racial group. Further study is needed to determine if these results are associated with improved survival and less morbidity in this minority group.


Subject(s)
Kidney Failure, Chronic/ethnology , Kidney Failure, Chronic/mortality , Renal Dialysis/mortality , Adolescent , Adult , Black or African American/statistics & numerical data , Aged , Anemia/ethnology , Anemia/mortality , Anemia/therapy , Arteriovenous Shunt, Surgical/statistics & numerical data , Asian People/ethnology , Asian People/statistics & numerical data , Female , Humans , Incidence , Kidney Failure, Chronic/therapy , Male , Middle Aged , Multivariate Analysis , Prevalence , Serum Albumin , Treatment Outcome , United States/epidemiology , White People/statistics & numerical data
4.
Am J Kidney Dis ; 41(2): 433-41, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12552507

ABSTRACT

BACKGROUND: Urea reduction ratio (URR) and hematocrit values reported on the Centers for Medicare & Medicaid Services (CMS) claims were compared with data from two different databases. METHODS: URRs and hematocrits from two different CMS databases (National Claims History and End-Stage Renal Disease Clinical Performance Measures [CPM] Project) and one Network database (The Renal Network Data System [TRNDS]) were compared for October through December 1998 and December 1998, respectively. A sample of records from the regional database was validated by independent chart review. RESULTS: Nationally, the percentage of agreement for patients with URRs of 65% or greater and less than 65% was 94% (kappa, 0.81; 95% confidence interval [CI], 0.80 to 0.83); regionally, the percentage of agreement was 95% (kappa, 0.85; 95% CI, 0.84 to 0.86). Nationally, linear regression of hematocrit values from both data sources yielded r(2) congruent with 0.61 each month and r(2) = 0.70 for average values during the 3-month study period. Nationally, the percentage of agreement for patients with hematocrits of 33% or greater and less than 33% was 84% (kappa approximately 0.66) each month. Regionally, linear regression of monthly hematocrit values from both data sources yielded r(2) = 0.66, and percentage of agreement for patients with hematocrits of 33% or greater and less than 33% was 87% (kappa, 0.71; 95% CI, 0.70 to 0.73). Validation of a sample of records in the TRNDS database resulted in 98% agreement for patients with URRs of 65% or greater and less than 65% and 96% agreement for patients with hematocrits of 33% or greater and less than 33%. CONCLUSION: Although there is general agreement between clinical variables submitted on the claims and in the CPM Project, some variation exists. Data from either source yield the same information when classifying patients as above or below threshold values.


Subject(s)
Centers for Medicare and Medicaid Services, U.S./statistics & numerical data , Databases, Factual , Hematocrit/statistics & numerical data , Urea/metabolism , Urea/urine , Anemia/therapy , Blood Urea Nitrogen , Computer Communication Networks/statistics & numerical data , Databases, Factual/statistics & numerical data , Humans , Regional Medical Programs/statistics & numerical data , Renal Dialysis/statistics & numerical data , Sampling Studies , United States
5.
Health Care Financ Rev ; 23(4): 37-50, 2002.
Article in English | MEDLINE | ID: mdl-12500469

ABSTRACT

The Balanced Budget Act (BBA) of 1997 directed CMS to implement a system to measure and report the quality of dialysis services under Medicare by 2000. Because of this tight timeframe, a rapid-cycle measurement development process was initiated to develop dialysis facility-specific measures that could be released to the public. The result was "Dialysis Facility Compare" which has served as a template for the development of public reporting initiatives for other providers in the Medicare Program. This article describes the process used for developing and reporting these performance measures and the lessons learned for future work in this area.


Subject(s)
Information Dissemination , Medicare/standards , Quality Indicators, Health Care , Renal Dialysis/standards , Ambulatory Care Facilities/standards , Benchmarking , Centers for Medicare and Medicaid Services, U.S. , Hemodialysis Units, Hospital/standards , Humans , Internet , Public Relations , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...